Source: ACS Medicinal Chemistry Letters. Unidades: ICB, FCF
Subjects: MICROBIOLOGIA, ANTIFÚNGICOS, MICOLOGIA MÉDICA, CANDIDA, ASPERGILLUS, CITOTOXINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARGOMEDO, Luis Miguel Zaravia et al. Novel 2-Aryloxazoline compounds exhibit an inhibitory effect on Candida spp., including antifungal-resistant isolates. ACS Medicinal Chemistry Letters, v. 11, n. 12, p. 2470–2475, 2020Tradução . . Disponível em: https://doi.org/10.1021/acsmedchemlett.0c00449. Acesso em: 03 set. 2024.APA
Argomedo, L. M. Z., Barroso, V. de M., Barreiro, C. de S., Rocha, M. P. D., Ishida, K., & Stefani, H. A. (2020). Novel 2-Aryloxazoline compounds exhibit an inhibitory effect on Candida spp., including antifungal-resistant isolates. ACS Medicinal Chemistry Letters, 11( 12), 2470–2475. doi:10.1021/acsmedchemlett.0c00449NLM
Argomedo LMZ, Barroso V de M, Barreiro C de S, Rocha MPD, Ishida K, Stefani HA. Novel 2-Aryloxazoline compounds exhibit an inhibitory effect on Candida spp., including antifungal-resistant isolates [Internet]. ACS Medicinal Chemistry Letters. 2020 ; 11( 12): 2470–2475.[citado 2024 set. 03 ] Available from: https://doi.org/10.1021/acsmedchemlett.0c00449Vancouver
Argomedo LMZ, Barroso V de M, Barreiro C de S, Rocha MPD, Ishida K, Stefani HA. Novel 2-Aryloxazoline compounds exhibit an inhibitory effect on Candida spp., including antifungal-resistant isolates [Internet]. ACS Medicinal Chemistry Letters. 2020 ; 11( 12): 2470–2475.[citado 2024 set. 03 ] Available from: https://doi.org/10.1021/acsmedchemlett.0c00449